Study shows promise of precision medicine for most common type of lymphoma
Tuesday, July 21, 2015 - 10:20
in Health & Medicine
A clinical trial has shown that patients with a specific molecular subtype of diffuse large B-cell lymphoma (DLBCL) are more likely to respond to the drug ibrutinib (Imbruvica) than patients […]